These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data. Kim WG, Kim TY, Kim TH, Jang HW, Jo YS, Park YJ, Kim SW, Kim WB, Shong M, Park DJ, Chung JH, Shong YK, Cho BY. Korean J Intern Med; 2014 May; 29(3):325-33. PubMed ID: 24851067 [Abstract] [Full Text] [Related]
31. Clinical Implication of World Health Organization Classification in Patients with Follicular Thyroid Carcinoma in South Korea: A Multicenter Cohort Study. Jin M, Kim ES, Kim BH, Kim HK, Yi HS, Jeon MJ, Kim TY, Kang HC, Kim WB, Shong YK, Kim M, Kim WG. Endocrinol Metab (Seoul); 2020 Sep; 35(3):618-627. PubMed ID: 32981304 [Abstract] [Full Text] [Related]
35. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA. Wang N, Liu T, Sofiadis A, Juhlin CC, Zedenius J, Höög A, Larsson C, Xu D. Cancer; 2014 Oct 01; 120(19):2965-79. PubMed ID: 24898513 [Abstract] [Full Text] [Related]
39. Selective treatment of differentiated thyroid carcinoma. Gemsenjäger E, Heitz PU, Martina B. World J Surg; 1997 Jun 01; 21(5):546-51; discussion 551-2. PubMed ID: 9204746 [Abstract] [Full Text] [Related]